Press Releases

Summary Toggle Chembio Diagnostics Reports 2013 Financial Results

Mar 6, 2014

Conference Call and Webcast Today at 10:00 a.m. Eastern

Read more

Chembio Diagnostics Reports 2013 Financial Results 49.9 KB
Summary Toggle Chembio to Host Conference Call to Discuss 2013 Financial Results

Feb 20, 2014

Conference Call Scheduled for Thursday, March 6th at 10:00 a.m. Eastern Time

Read more

Chembio to Host Conference Call to Discuss 2013 Financial Results 36 KB
Summary Toggle Chembio Enters Agreements With RVR in Southeast Asia

Feb 12, 2014

Agreements Provide Access to New Markets & Potential Cost-Effective Supplier

Read more

Chembio Enters Agreements With RVR in Southeast Asia 35.1 KB
Summary Toggle Chembio Provides Update on DPP(R) HIV 1/2 Assay CLIA Waiver Application

Feb 10, 2014

MEDFORD, N.Y. , Feb. 10, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care diagnostic tests for infectious diseases, today provided an update on its discussions with the U.S. Food and Drug Administration (FDA) concerning the company's CLIA waiver application
Read more

Chembio Provides Update on DPP(R) HIV 1/2 Assay CLIA Waiver Application 33.6 KB
Summary Toggle Chembio Diagnostics to Present at Three Conferences in January 2014

Jan 9, 2014

MEDFORD, N.Y., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that Lawrence A. Siebert, Chief Executive Officer, will present at three investor conferences next week.
Read more

Chembio Diagnostics to Present at Three Conferences in January 2014 36.9 KB
Summary Toggle Chembio to Present at the LD Micro VI: The Main Event Conference

Dec 3, 2013

MEDFORD, N.Y. , Dec. 3, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announces that Lawrence A. Siebert , Chief Executive Officer, will present at the LD Micro VI: The Main Event Conference to be held
Read more

Chembio to Present at the LD Micro VI: The Main Event Conference 34.4 KB
Summary Toggle Chembio Files for CLIA Waiver with FDA for Point-of-Care DPP(R) HIV 1/2 Assay

Dec 2, 2013

MEDFORD, N.Y. , Dec. 2, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, has completed its Clinical Laboratory Improvement Amendment ("CLIA") waiver studies for its DPP® HIV 1/2 Assay (the "Assay").
Read more

Chembio Files for CLIA Waiver with FDA for Point-of-Care DPP(R) HIV 1/2 Assay 40.8 KB
Summary Toggle Chembio Board Member Named Winner of Commercialization Award by Purdue University

Nov 21, 2013

Dr. Peter Kissinger Recognized for Role in Commercializing Purdue Research Discoveries

Read more

Chembio Board Member Named Winner of Commercialization Award by Purdue University 33.9 KB
Summary Toggle Chembio Diagnostics Reports Third Quarter 2013 Financial Results

Nov 7, 2013

Conference Call and Webcast Today at 4:30 pm Eastern

Read more

Chembio Diagnostics Reports Third Quarter 2013 Financial Results 51 KB
Summary Toggle Chembio Launches DPP(R) HIV-Syphilis Test

Oct 31, 2013

Receives First Purchase Order from Mexican Distributor Multiplex HIV-Syphilis Assay Approved for USAID Waiver List, Now Eligible for U.S. Global Aid Procurements MEDFORD, N.Y., Oct. 31, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in the development, manufacture and
Read more

Chembio Launches DPP(R) HIV-Syphilis Test 35.1 KB